United States · Wires & real time · PR Newswire
TARGET Study Demonstrates Sustained Performance and Favorable Safety Profile of the Cardiovalve TR System in High-Risk Patients with Severe Tricuspid Regurgitation

Detailed summary
Late-breaking 6-month full cohort data presented at PCR London Valves 2026 shows durable tricuspid regurgitation reduction up to 3 years, positive right heart remodeling and…
MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.prnewswire.com)
